Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

NorthX Biologics AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 187,537 Less Arrow 110,926 More Arrow 150,341
Financial expenses 976 Less Arrow 214 More Arrow 746
Earnings before taxes -59,256 Less Arrow -74,716 More Arrow -11,108
EBITDA -42,283 Less Arrow -63,416 More Arrow -4,101
Total assets 341,357 More Arrow 363,882 Less Arrow 261,461
Current assets 165,610 More Arrow 168,488 Less Arrow 130,569
Current liabilities 339,966 Less Arrow 316,845 Less Arrow 253,988
Equity capital 1,280 More Arrow 47,037 Less Arrow 7,473
- share capital 103 Less Arrow 101 Less Arrow 95
Employees (average) 116 More Arrow 145 Less Arrow 129

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 0.4% More Arrow 12.9% Less Arrow 2.9%
Turnover per employee 1,617 Less Arrow 765 More Arrow 1,165
Profit as a percentage of turnover -31.6% Less Arrow -67.4% More Arrow -7.4%
Return on assets (ROA) -17.1% Less Arrow -20.5% More Arrow -4.0%
Current ratio 48.7% More Arrow 53.2% Less Arrow 51.4%
Return on equity (ROE) -4629.4% More Arrow -158.8% More Arrow -148.6%
Change turnover 74,611 Less Arrow -50,083 More Arrow 19,286
Change turnover % 66% Less Arrow -31% More Arrow 15%
Chg. No. of employees -29 More Arrow 16 Less Arrow 5
Chg. No. of employees % -20% More Arrow 12% Less Arrow 4%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.